Denali Therapeutics Inc.DNLINASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-2.24%
↓ 124% below average
Average (38q)
9.48%
Historical baseline
Range
High:520.56%
Low:-154.18%
Volatility
7115.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -2.24% |
| Q2 2025 | 6.66% |
| Q1 2025 | -15.87% |
| Q4 2024 | -7.05% |
| Q3 2024 | -8.25% |
| Q2 2024 | 2.73% |
| Q1 2024 | 14.79% |
| Q4 2023 | -20.25% |
| Q3 2023 | -154.18% |
| Q2 2023 | 267.04% |
| Q1 2023 | -11.25% |
| Q4 2022 | 4.47% |
| Q3 2022 | -75.70% |
| Q2 2022 | 9.85% |
| Q1 2022 | 13.34% |
| Q4 2021 | 11.03% |
| Q3 2021 | -39.37% |
| Q2 2021 | 13.35% |
| Q1 2021 | -128.60% |
| Q4 2020 | 520.56% |
| Q3 2020 | 0.90% |
| Q2 2020 | -3.51% |
| Q1 2020 | -5.07% |
| Q4 2019 | -16.79% |
| Q3 2019 | 20.70% |
| Q2 2019 | -49.61% |
| Q1 2019 | -150.29% |
| Q4 2018 | 319.20% |
| Q3 2018 | 35.36% |
| Q2 2018 | -131.12% |
| Q1 2018 | -3.46% |
| Q4 2017 | -4.77% |
| Q3 2017 | 1.31% |
| Q2 2017 | -3.82% |
| Q1 2017 | -10.16% |
| Q4 2016 | 36.77% |
| Q3 2016 | -66.88% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |